Erastin has been shown to inhibit SLC7A11, which functions in the Nrf2/Keap1 pathway in N5CP and A549 cells33,34, and sensitizes NSCLC cells to the chemotherapeutic drug celastrol35. This evidence concerns the gene KEAP1 and non-small cell lung carcinoma.